Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu.V. Rybchenko
Pharmacoeconomic Study of Herceptin® (Trastuzumab) for Breast Cancer Patients
Pharmacoeconomics: theory and practice
Related publications
Trastuzumab (Herceptin)
American Journal of Neuroradiology
Medicine
Nuclear Medicine
Neurology
Imaging
Radiology
Safety of Trastuzumab (Herceptin®) During Pregnancy: Two Case Reports
Cases Journal
Direct Detection of Herceptin/Trastuzumab Binding on Breast Tissue Sections
Journal of Histochemistry and Cytochemistry
Anatomy
Histology
Substituting Adjuvant Trastuzumab Emtansine for Herceptin Improves Survival in Patients With Human Epidermal Growth Factor Receptor 2–positive Breast Cancer
Cancer
Cancer Research
Oncology
Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin®)
BioDrugs
Medicine
Biotechnology
Pharmacology
Pcn103 - Predicted Treatment Costs and Savings Per Patient of Kanjinti® (Trastuzumab Biosimilar) vs. Subcutaneous (Sc) and Intravenous (Iv) Herceptin® and Other Trastuzumab Biosimilars in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Trastuzumab-Containing Regimens for Metastatic Breast Cancer
Cochrane Database of Systematic Reviews
Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer
JAMA Oncology
Cancer Research
Oncology
The Evaluation of Left Ventricular Function for Patients Being Considered For, or Receiving Trastuzumab (Herceptin) Therapy
British Journal of Cancer
Cancer Research
Oncology